BioCentury
ARTICLE | Clinical News

FDA approves Biocodex's Diacomit for Dravet syndrome seizures

August 31, 2018 5:59 PM UTC

FDA approved Diacomit stiripentol from Laboratoires Biocodex (Gentilly, France) to treat seizures associated with Dravet syndrome in patients ages two and older who are taking clobazam. The anticonvu...

BCIQ Company Profiles

Laboratoires Biocodex

BCIQ Target Profiles

Cytochrome P450 (p450)